1. Nanoparticles assembled from fucoidan and trimethylchitosan as anthrax vaccine adjuvant: In vitro and in vivo efficacy in comparison to CpG
- Author
-
Xin-an Chen, Chuan-chang Chuang, Jyh-Hwa Kau, Meng-Hung Tsai, Hui-ju Yen, Huey-Fen Shyu, Jenn-jong Young, Kuang-ming Cheng, Cheng-Cheung Chen, and Chia-ying Lee
- Subjects
Polymers and Plastics ,CpG Oligodeoxynucleotide ,medicine.medical_treatment ,02 engineering and technology ,Anthrax Vaccines ,010402 general chemistry ,01 natural sciences ,Anthrax ,chemistry.chemical_compound ,Mice ,Adjuvants, Immunologic ,In vivo ,Polysaccharides ,Materials Chemistry ,medicine ,Animals ,Humans ,Chitosan ,Anthrax vaccines ,Fucoidan ,Organic Chemistry ,Antibody titer ,Anthrax Vaccine Adsorbed ,021001 nanoscience & nanotechnology ,Molecular biology ,0104 chemical sciences ,chemistry ,Oligodeoxyribonucleotides ,A549 Cells ,Bacillus anthracis ,Humoral immunity ,Cytokines ,Nanoparticles ,Female ,0210 nano-technology ,Adjuvant - Abstract
Fucoidan/trimethylchitosan nanoparticles (FUC-TMC-NPs) have the potential to improve the immunostimulating efficiency of anthrax vaccine adsorbed (AVA). FUC-TMC-NPs with positive (+) or negative (–) surface charges were prepared via polyelectrolyte complexation, both charged NP types permitted high viability and presented no cytotoxicity on L929, A549 and JAWS II dendritic cells. Flow cytometry measurements indicated lower (+)-FUC-TMC-NPs internalization levels than (–)-FUC-TMC-NPs, yet produced high levels of pro-inflammatory cytokines IFN-γ, IL12p40, and IL-4. Moreover, fluorescence microscope images proved that both charged NP could deliver drugs into the nucleus. In vivo studies on A/J mice showed that (+)-FUC-TMC-NPs carrying AVA triggered an efficient response with a higher IgG anti-PA antibody titer than AVA with CpG oligodeoxynucleotides, and yielded 100 % protection when challenged with the anthracis spores. Furthermore, PA-specific IgG1 and IgG2a analysis confirmed that (+)-FUC-TMC-NPs strongly stimulated humoral immunity. In conclusion, (+)-FUC-TMC-NP is promising anthrax vaccine adjuvant as an alternative to CpG.
- Published
- 2019